Sign In
Buy EVGN
$0.599
+0.0089 (+1.51%)
At Close: Jun 03, 2026
Evogene Trades Down On Q4 Results, CEO Says 2019 Was 'Turning Point'
04:54pm, Wednesday, 04'th Mar 2020Stocks That Hit 52-Week Lows On Wednesday
04:12pm, Wednesday, 04'th Mar 2020
Wednesday's morning session saw 132 companies set new 52-week lows.
Intriguing Points:
HDFC Bank (NYSE: HDB) was the biggest company by market cap to set a new 52-...
Evogene Reports Fourth Quarter and Full Year 2019 Financial Results
12:00pm, Wednesday, 04'th Mar 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading company in leveraging computational biology to design novel products for life-science-based industries, announces today its financial results for
Evogene to Attend in Bank of America 2020 Global Agriculture and Materials Conference
12:00pm, Tuesday, 25'th Feb 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading company in leveraging computational biology to design novel products for life-science-based industries including: human health, agriculture and i
Evogene Financial Results for the Fourth Quarter and Full Year of 2019 Earnings Announcement Schedule
12:00pm, Wednesday, 12'th Feb 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading company in leveraging computational biology to design novel products for life-science-based industries including: human health, agriculture and indu
The Week In Cannabis: MedMen And Sundial Lose Their CEOs, Santa Cruz Gets Trippy And Much More
09:36pm, Sunday, 02'nd Feb 2020
A week filled of cannabis news ended with the departure of MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF)’s CEO Adam Bierman, who left the company after a massive...
Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) and (TASE: EVGN) focused on the development of medical cannabis products, announces today an agreement with Hadasit, Hadassah Medical
Canonic Partners With Hadassah Medical Center For Pre-Clinical Studies To Help Cannabis Product Development
12:00am, Monday, 27'th Jan 2020
Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has entered a
Hedge Funds Have Never Been More Bullish On Evogene Ltd. (EVGN)
11:57pm, Sunday, 22'nd Dec 2019
Is Evogene Ltd. (NASDAQ:EVGN) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have num
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
12:00am, Friday, 06'th Dec 2019Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants
12:00pm, Monday, 18'th Nov 2019
Leading wheat bio-stimulant candidate for spring wheat, exhibiting consistent performance, advancing to 'development stage 2', in line with Lavie Bio's commercialization plans for 2022 REHOVOT, Israel
Evogene Reports Third Quarter 2019 Financial Results
12:00pm, Wednesday, 13'th Nov 2019
Conference call and webcast: November 13th, 9:00 am ET REHOVOT, Israel , Nov. 13, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel produ
